Gregory James Zahner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 13 | 2020 | 1113 | 2.310 |
Why?
|
| Medicare Part C | 2 | 2022 | 251 | 1.340 |
Why?
|
| Intermittent Claudication | 3 | 2019 | 304 | 1.270 |
Why?
|
| Radial Artery | 3 | 2018 | 211 | 1.160 |
Why?
|
| Manometry | 3 | 2018 | 416 | 1.150 |
Why?
|
| Veterans Health | 2 | 2018 | 197 | 0.750 |
Why?
|
| Donor Selection | 1 | 2020 | 190 | 0.710 |
Why?
|
| Blood Donors | 1 | 2020 | 354 | 0.680 |
Why?
|
| Amputation | 2 | 2019 | 763 | 0.630 |
Why?
|
| Vasodilation | 2 | 2018 | 957 | 0.610 |
Why?
|
| Ischemia | 2 | 2020 | 1906 | 0.500 |
Why?
|
| Depression | 4 | 2020 | 7267 | 0.460 |
Why?
|
| Leptin | 1 | 2019 | 1574 | 0.400 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1942 | 0.350 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2019 | 857 | 0.280 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2019 | 1294 | 0.270 |
Why?
|
| Inflammation | 2 | 2019 | 10086 | 0.220 |
Why?
|
| Insurance Coverage | 2 | 2022 | 1863 | 0.190 |
Why?
|
| United States | 9 | 2022 | 67939 | 0.190 |
Why?
|
| Cost Control | 1 | 2022 | 626 | 0.180 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2022 | 336 | 0.180 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 23443 | 0.170 |
Why?
|
| Resistin | 1 | 2018 | 172 | 0.170 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2019 | 551 | 0.160 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 444 | 0.160 |
Why?
|
| Risk Assessment | 7 | 2020 | 23485 | 0.160 |
Why?
|
| Limb Salvage | 1 | 2019 | 423 | 0.160 |
Why?
|
| Ankle Brachial Index | 1 | 2017 | 150 | 0.150 |
Why?
|
| Education, Professional | 1 | 2017 | 51 | 0.150 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2019 | 404 | 0.150 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 542 | 0.140 |
Why?
|
| Heart Diseases | 2 | 2018 | 2755 | 0.140 |
Why?
|
| HIV Infections | 1 | 2020 | 15784 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2018 | 1170 | 0.130 |
Why?
|
| Aged | 13 | 2020 | 162518 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12490 | 0.120 |
Why?
|
| Fish Oils | 1 | 2017 | 463 | 0.120 |
Why?
|
| Adiponectin | 1 | 2019 | 1089 | 0.110 |
Why?
|
| Problem-Based Learning | 1 | 2016 | 341 | 0.110 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 856 | 0.110 |
Why?
|
| Inpatients | 2 | 2020 | 2255 | 0.110 |
Why?
|
| Vascular Surgical Procedures | 1 | 2020 | 1451 | 0.110 |
Why?
|
| Middle Aged | 12 | 2020 | 214757 | 0.110 |
Why?
|
| Affect | 1 | 2019 | 1494 | 0.110 |
Why?
|
| Risk Factors | 7 | 2020 | 70927 | 0.110 |
Why?
|
| Male | 16 | 2020 | 350411 | 0.100 |
Why?
|
| Comorbidity | 3 | 2020 | 10436 | 0.100 |
Why?
|
| Critical Illness | 2 | 2020 | 2529 | 0.100 |
Why?
|
| Clinical Clerkship | 1 | 2016 | 519 | 0.100 |
Why?
|
| Female | 15 | 2020 | 377334 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2018 | 3172 | 0.080 |
Why?
|
| Dietary Supplements | 2 | 2019 | 3111 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2020 | 3030 | 0.080 |
Why?
|
| Linear Models | 1 | 2018 | 5996 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2020 | 7895 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 1927 | 0.080 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 993 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4459 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3720 | 0.070 |
Why?
|
| Veterans | 1 | 2019 | 2239 | 0.070 |
Why?
|
| Mental Health | 1 | 2019 | 2680 | 0.070 |
Why?
|
| Heart Rate | 1 | 2017 | 4096 | 0.070 |
Why?
|
| Humans | 17 | 2021 | 715914 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 4587 | 0.070 |
Why?
|
| Cardiology | 1 | 2016 | 1645 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2017 | 9993 | 0.060 |
Why?
|
| Time Factors | 3 | 2020 | 40903 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 29010 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 58328 | 0.050 |
Why?
|
| Logistic Models | 1 | 2017 | 13630 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2020 | 72458 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15200 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2020 | 62019 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15926 | 0.050 |
Why?
|
| Stroke | 2 | 2018 | 9507 | 0.050 |
Why?
|
| Chromatography, Gas | 1 | 2019 | 169 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21820 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15080 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2019 | 435 | 0.040 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2019 | 227 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 11405 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6724 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 403 | 0.030 |
Why?
|
| Placebos | 1 | 2019 | 1736 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 2018 | 847 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2018 | 607 | 0.030 |
Why?
|
| Curriculum | 2 | 2017 | 3402 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 20528 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 12474 | 0.030 |
Why?
|
| California | 1 | 2017 | 1396 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 3957 | 0.030 |
Why?
|
| Mentors | 1 | 2016 | 612 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 1312 | 0.020 |
Why?
|
| Program Development | 1 | 2016 | 1328 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2021 | 2270 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4313 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2016 | 2595 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2016 | 2539 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10672 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2020 | 9028 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 2827 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 11948 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 11722 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2016 | 3741 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20764 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40050 | 0.010 |
Why?
|